MedTrace Logo

Effect of Arista Powder on Bleeding in Reductive Mammary Surgery

NCT00227084 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2007-08-27

No results posted yet for this study

Summary

To evaluate whether Arista AH which contains microporous polysaccharides used as a powder applied to the wound area during mammary surgery reduces the amount of bleeding and the duration of surgery. Both mammae are operated on in the same procedure, and one side without Arista serves as control side

Conditions

  • Mammaplasty

Interventions

DRUG

Arista AH hemostasis powder

Sponsors & Collaborators

  • Ullevaal University Hospital

    collaborator OTHER

  • Medafor

    collaborator UNKNOWN

  • University of Oslo

    lead OTHER

Principal Investigators

  • Christian Askenberg, MD · Ullevaal University Hospital

  • Petter A Steen, MD,PhD · University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2006-10-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00227084 on ClinicalTrials.gov